Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed byin vivotwo-photon imaging
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed byin vivotwo-photon imaging
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 12, Issue 12, Pages 2120-2130
Publisher
Wiley
Online
2014-09-29
DOI
10.1111/jth.12738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?
- (2013) Maurizio Zangari et al. BLOOD COAGULATION & FIBRINOLYSIS
- Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography
- (2013) Hyun Seung Yang et al. BRITISH JOURNAL OF HAEMATOLOGY
- In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice
- (2012) Thom P. Santisakultarm et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model
- (2012) L. Kubovcakova et al. BLOOD
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera
- (2011) Marina Panova-Noeva et al. AMERICAN JOURNAL OF HEMATOLOGY
- Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146+ immunomagnetic enrichment-flow cytometry and soluble E-selectin detection
- (2011) Angelo Belotti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- Neurological disorders in essential thrombocythemia
- (2011) S. Billot et al. HAEMATOLOGICA
- Optically quantified cerebral blood flow
- (2011) Thom P Santisakultarm et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
- (2011) H Reikvam et al. LEUKEMIA
- Ischaemic stroke and essential thrombocythemia: a series of 14 cases
- (2010) S. Richard et al. EUROPEAN JOURNAL OF NEUROLOGY
- Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms
- (2010) Jérôme Duchemin et al. THROMBOSIS RESEARCH
- Endothelial Dysfunction in Lacunar Stroke: A Systematic Review
- (2009) Iris L.H. Knottnerus et al. CEREBROVASCULAR DISEASES
- Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders
- (2009) Ana L. Basquiera et al. Hematology
- Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden
- (2008) Eduardo Arellano-Rodrigo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Platelet count in essential thrombocythemia: the more the better?
- (2008) A. Tefferi BLOOD
- Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
- (2008) Alessandra Carobbio et al. JOURNAL OF CLINICAL ONCOLOGY
- A Role for JAK2 Mutations in Myeloproliferative Diseases
- (2007) Kelly J. Morgan et al. Annual Review of Medicine
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started